Certara (NASDAQ:CERT) Stock Price Down 3.1%

Certara, Inc. (NASDAQ:CERT) traded down 3.1% on Thursday . The stock traded as low as $13.44 and last traded at $13.51. 24,912 shares were traded during mid-day trading, a decline of 96% from the average session volume of 554,677 shares. The stock had previously closed at $13.94.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on the company. KeyCorp raised Certara from a “sector weight” rating to an “overweight” rating and set a $23.00 price objective on the stock in a report on Wednesday, April 10th. UBS Group lifted their price objective on Certara from $17.00 to $20.00 and gave the company a “neutral” rating in a report on Friday, March 1st. Jefferies Financial Group lifted their price objective on Certara from $14.00 to $15.50 and gave the company a “hold” rating in a report on Friday, March 1st. Finally, JMP Securities assumed coverage on Certara in a report on Thursday, April 4th. They set a “market perform” rating on the stock. Seven analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat, the company has a consensus rating of “Hold” and an average price target of $20.06.

Certara Price Performance

The business’s 50 day moving average price is $16.12 and its 200-day moving average price is $16.91. The company has a quick ratio of 3.26, a current ratio of 3.26 and a debt-to-equity ratio of 0.27.

Certara (NASDAQ:CERT) last posted its earnings results on Tuesday, May 7th. The company reported $0.06 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.07 by ($0.01). Certara had a negative net margin of 17.02% and a positive return on equity of 4.08%. The firm had revenue of $96.65 million during the quarter, compared to the consensus estimate of $94.48 million. As a group, sell-side analysts anticipate that Certara, Inc. will post 0.29 EPS for the current year.

Insider Buying and Selling

In related news, SVP Richard M. Traynor sold 3,000 shares of the business’s stock in a transaction that occurred on Monday, April 1st. The shares were sold at an average price of $18.00, for a total value of $54,000.00. Following the completion of the transaction, the senior vice president now owns 173,524 shares in the company, valued at approximately $3,123,432. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other Certara news, insider Patrick F. Smith sold 14,427 shares of the company’s stock in a transaction on Tuesday, April 2nd. The shares were sold at an average price of $16.85, for a total transaction of $243,094.95. Following the completion of the sale, the insider now owns 50,091 shares in the company, valued at approximately $844,033.35. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Richard M. Traynor sold 3,000 shares of the company’s stock in a transaction on Monday, April 1st. The shares were sold at an average price of $18.00, for a total transaction of $54,000.00. Following the sale, the senior vice president now owns 173,524 shares of the company’s stock, valued at approximately $3,123,432. The disclosure for this sale can be found here. 2.39% of the stock is currently owned by corporate insiders.

Institutional Trading of Certara

Institutional investors and hedge funds have recently made changes to their positions in the business. Pineridge Advisors LLC bought a new stake in shares of Certara during the 4th quarter valued at $28,000. Global Retirement Partners LLC raised its position in shares of Certara by 5,306.3% during the 1st quarter. Global Retirement Partners LLC now owns 1,730 shares of the company’s stock valued at $31,000 after acquiring an additional 1,698 shares during the last quarter. YHB Investment Advisors Inc. bought a new stake in shares of Certara during the 1st quarter valued at $47,000. Covestor Ltd raised its position in shares of Certara by 14,940.0% during the 3rd quarter. Covestor Ltd now owns 3,760 shares of the company’s stock valued at $55,000 after acquiring an additional 3,735 shares during the last quarter. Finally, Natixis Advisors L.P. raised its position in shares of Certara by 13.4% during the 3rd quarter. Natixis Advisors L.P. now owns 15,136 shares of the company’s stock valued at $220,000 after acquiring an additional 1,791 shares during the last quarter. Institutional investors own 73.96% of the company’s stock.

Certara Company Profile

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.